Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

Arthroplasty implant systems and procedures are disclosed herein. In an embodiment, an arthroplasty implant of an arthroplasty system includes a shape memory material connecting member attached to two points of fixation of the arthroplasty implant.

A load dissipating arthroplasty prosthesis comprising a shell, an articular device extending into the shell through a collar defined in the sell, a head and neck portion of the articular device extending from the collar, a shaft portion of the articular device extending into the shell, and a plurality of shock absorbing arcuate linkers spacing and allowing limited movement between the shell and the articular device.

A continuous compression fixation device for coupling a first bony structure to a second bony structure, including: a body structure; and a plurality of arm structures extending from the body structure, wherein at least one of the plurality of arm structures is configured to be coupled to the first bony structure and at least one opposed one of the plurality of arm structures is configured to be coupled to the second bony structure; wherein the body structure and the plurality of arm structures are manufactured from a shape memory material; and wherein tips of the at least one of the plurality of arm structures and the at least one opposed one of the plurality of arm structures are biased towards one another such that a desired compressive force is applied to an intercalary structural augment disposed between the first bony structure and the second bony structure.

A standalone anterior cervical interbody spacer (ACIF) that includes a spacer body and plate rigidly couple via flexible pins.

An implant is insertable in the joint space to separate bones of the joint. The implant has two endplates each configured to engage a separate articulating bone of the joint, and a threaded member positioned between the two endplates and configured to increase the space between the two endplates when the threaded member is rotated. A rotatable gear is engaged with the threaded member, and is engageable with a rotating gear of a connected implantation tool, so that rotation of the gear on the tool causes rotation of the threaded member and expansion of the implant to separate the bones. Connector portions on the tool and the implant may be rotated together to securely engage the implant and the tool so that the gears of the tool and the implant can be rotated using an actuator outside of the body, when the implant is inside the body.

An acetabular cup assembly for use with liners is described. The acetabular cup assembly includes a cup and a liner. The cup has an outer surface, a generally concave inner surface and a top face. The inner surface includes a cylindrical band having a plurality of inward-facing recessed scallops, a tapered wall adjacent to the band, and an inner spherical surface adjacent the tapered wall. The inner spherical surface has a substantially uniform radius of curvature. A single groove interrupts the spherical surface. The liner has a substantially convex outer surface and includes a rim and a plurality of outward-projecting scallops adjacent the rim. The scallops of the liner are configured to engage the scallops of the cup when the liner is seated in the cup. Related methods of use are also provided.

The invention concerns a prosthesis comprising: a stem part comprising: a rod, configured for being inserted into a medullary cavity of a diaphyseal fragment of a fractured long bone, for securing the stem part to the diaphyseal fragment, and an epiphyseal end, fixedly secured to the rod by means of at least one linker leg of the stem part, so that a gap is formed between the epiphyseal end and the rod along said at least one linker leg; and an implant distinct from the stem part and comprising: an internal part located at least partially within the gap, and at least one fastener for fastening epiphyseal fragments of the fractured long bone to the stem part, said at least one fastener being secured to the internal part.

An intervertebral cage and intervertebral cage apparatus and a method for using the intervertebral cage and/or the intervertebral cage apparatus. The intervertebral cage can be any desired material including a memory material. The intervertebral cage apparatus can include the intervertebral cage and one or both of a variable volume pouch and a deployment cable. The variable volume pouch can be inserted into an internal volume of the intervertebral cage and affixed to the intervertebral cage. The variable volume pouch can be filled with material to achieve an expanded state. The variable volume pouch can assist in the deployment of the intervertebral cage. The deployment cable can be attached to the intervertebral cage and can include features to facilitate that attachment. The deployment cable can apply a force to the intervertebral cage to deploy the intervertebral cage, and can include features to lock the intervertebral cage in the deployed configuration. An implantation tool can be used to apply force to the intervertebral cage to deploy the intervertebral cage.

The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes a pharmaceutical for use by a male and a first label coupled to the first package, wherein at least one of the first package and first label includes a male specifier and a recommended male dosage. The second package includes a pharmaceutical for use by a female and a second label coupled to the second package, wherein at least one of the second package and second label includes a female specifier and a recommended female dosage.